MiTF by IHC

Alphabetical Test listing

MiTF by IHC-12376 - Technical only, 12379 - Technical & Interpretation

  
MiTF by IHC
  
12376 - Technical only, 12379 - Technical & Interpretation
  
LAB12376
LAB12379
  
Microphthalmia transcription factor
  
  • All IHC stains will include a positive control tissue
  
  • Anti MITF recognizes a nuclear protein which is expressed in most primary and metastatic epithelioid malignant melanomas
  • MITF is also seen in normal melanocytes, benign nevi and dysplastic nevi
  • This marker is present in a small subset of non-melanoma tissues and tumors (heart, macrophages, rare cells of pituitary, endometrial stromal cells, breast cancer, leiomyosarcoma, malignant mixed mullerian tumors, and renal cell carcinomas
  
Tissue
  

Submit a formalin-fixed, paraffin-embedded (FFPE) tissue block

  

FFPE tissue block

  

FFPE tissue section mounted on a charged, unstained slide

  

Ambient (preferred)

  
AHL - Immunohistochemistry
  
Mo - Fr
  
1 - 2 days
  

Immunohistochemical staining and microscopic examination

  

If requested, an interpretive report will be provided

  

Specifications

  • MITF is a transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium
  • It is also involved in the to enzyme genes such as tyrosinase, TRP1 and TRP2

Staining pattern

  • Nuclear

References

  1. Chang KL et al: Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv Anat Pathol. 2001; 8(5):273.
  2. Granter SR et al: Rogle for MITF in the diagnosis of metastatic malignant melanoma. Appl Immunhistochem Mol Morphol 2002; 10(1):47.
  
88342 - 1st stain
88341 - each additional stain
  
07/17/2017
  
10/19/2018
  
10/02/2020